These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 34676991)

  • 61. Past and Current Practice of Patient-Reported Outcome Measurement in Randomized Cancer Clinical Trials: A Systematic Review.
    Giesinger JM; Efficace F; Aaronson N; Calvert M; Kyte D; Cottone F; Cella D; Gamper EM
    Value Health; 2021 Apr; 24(4):585-591. PubMed ID: 33840437
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Harnessing the patient voice in prostate cancer research: Systematic review on the use of patient-reported outcomes in randomized controlled trials to support clinical decision-making.
    Van Hemelrijck M; Sparano F; Moris L; Beyer K; Cottone F; Sprangers M; Efficace F
    Cancer Med; 2020 Jun; 9(12):4039-4058. PubMed ID: 32333639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Reporting trends of outcome measures in phase II and phase III trials conducted in advanced-stage non-small-cell lung cancer.
    Ghimire S; Kyung E; Kim E
    Lung; 2013 Aug; 191(4):313-9. PubMed ID: 23715997
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sickle Cell Disease and Quality of Life: An Evaluation of Reporting of Patient-Reported Outcomes in Randomized Controlled Trials.
    Renner A; Love M; Garrett E; Douglas A; Kee M; Heigle B; Wise A; Ottwell R; Hartwell M; Vassar M
    Hemoglobin; 2022 Sep; 46(5):265-268. PubMed ID: 36268837
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Who are we missing? Language exclusivity of patient-reported outcomes in atrial fibrillation clinical trials.
    Lan RH; Guerrero EP; Lewis EF; Wang PJ
    J Cardiovasc Electrophysiol; 2024 Jul; ():. PubMed ID: 38953220
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Quality of patient-reported outcome reporting in randomised controlled trials of haematological malignancies according to international quality standards: a systematic review.
    Chakraborty R; Cannella L; Cottone F; Efficace F
    Lancet Haematol; 2020 Dec; 7(12):e892-e901. PubMed ID: 33242446
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
    Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
    Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quality of patient-reported outcome reporting in trials of diabetes in pregnancy: A systematic review.
    Newman C; Kgosidialwa O; Dervan L; Bogdanet D; Egan AM; Biesty L; Devane D; O'Shea PM; Dunne FP
    Diabetes Res Clin Pract; 2022 Jun; 188():109879. PubMed ID: 35483543
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Completion of Patient-Reported Outcome Questionnaires Among Older Adults with Advanced Cancer.
    Flannery MA; Mohile S; Culakova E; Norton S; Kamen C; Dionne-Odom JN; DiGiovanni G; Griggs L; Bradley T; Hopkins JO; Liu JJ; Loh KP
    J Pain Symptom Manage; 2022 Feb; 63(2):301-310. PubMed ID: 34371137
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patient-reported outcomes and the evolution of adverse event reporting in oncology.
    Trotti A; Colevas AD; Setser A; Basch E
    J Clin Oncol; 2007 Nov; 25(32):5121-7. PubMed ID: 17991931
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characteristics of Participation in Patient-Reported Outcomes and Electronic Data Capture Components of NRG Oncology Clinical Trials.
    Pugh SL; Rodgers JP; Yeager KA; Chen RC; Movsas B; Bonanni R; Dignam J; Bruner DW
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):950-959. PubMed ID: 32590048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAE.
    Watson GA; Veitch ZW; Shepshelovich D; Liu ZA; Spreafico A; Abdul Razak AR; Bedard PL; Siu LL; Minasian L; Hansen AR
    Br J Cancer; 2022 Nov; 127(9):1629-1635. PubMed ID: 36008705
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evaluating the use of the EORTC patient-reported outcome measures for improving inter-rater reliability of CTCAE ratings in a mixed population of cancer patients: study protocol for a randomized controlled trial.
    Wintner LM; Giesinger JM; Sztankay M; Bottomley A; Holzner B;
    Trials; 2020 Oct; 21(1):849. PubMed ID: 33050917
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comprehensive review of statistical methods for analysing patient-reported outcomes (PROs) used as primary outcomes in randomised controlled trials (RCTs) published by the UK's
    Qian Y; Walters SJ; Jacques R; Flight L
    BMJ Open; 2021 Sep; 11(9):e051673. PubMed ID: 34489292
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Current state of quality of life and patient-reported outcomes research.
    Bottomley A; Reijneveld JC; Koller M; Flechtner H; Tomaszewski KA; Greimel E;
    Eur J Cancer; 2019 Nov; 121():55-63. PubMed ID: 31561134
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial.
    Chi KN; Protheroe A; Rodríguez-Antolín A; Facchini G; Suttman H; Matsubara N; Ye Z; Keam B; Damião R; Li T; McQuarrie K; Jia B; De Porre P; Martin J; Todd MB; Fizazi K
    Lancet Oncol; 2018 Feb; 19(2):194-206. PubMed ID: 29326030
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis.
    Younossi ZM; Stepanova M; Feld J; Zeuzem S; Sulkowski M; Foster GR; Mangia A; Charlton M; O'Leary JG; Curry MP; Nader F; Henry L; Hunt S
    Clin Gastroenterol Hepatol; 2017 Mar; 15(3):421-430.e6. PubMed ID: 27847279
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Implementation of patient-reported outcome measures in real-world evidence studies: Analysis of ClinicalTrials.gov records (1999-2021).
    Maruszczyk K; Aiyegbusi OL; Cardoso VR; Gkoutos GV; Slater K; Collis P; Keeley T; Calvert MJ
    Contemp Clin Trials; 2022 Sep; 120():106882. PubMed ID: 35973663
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement.
    Fernandes LL; Zhou J; Kanapuru B; Horodniceanu E; Gwise T; Kluetz PG; Bhatnagar V
    Blood Cancer J; 2021 Aug; 11(8):148. PubMed ID: 34465728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.